Luye Pharma Group Limited — Earnings Release 2004

Nov 27, 2003

Listed Company Information

TAKSON HOLDINGS<00918> - Results Announcement Takson Holdings Limited announced on 27/11/2003: (stock code: 00918 ) Year end date: 31/03/2004 Currency: HKD Auditors' Report: N/A Review of Interim Report by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/04/2003 from 01/04/2002 to 30/09/2003 to 30/09/2002 Note ('000 ) ('000 ) Turnover : 147,620 231,906 Profit/(Loss) from Operations : 928 10,540 Finance cost : (735) (1,279) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : 787 9,393 % Change over Last Period : -92 % EPS/(LPS)-Basic (in dollars) : 0.002 0.0241 -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 787 9,393 Interim Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: Note: (1) Earnings per share The calculation of basic earnings per share is based on the Group's profit attributable to shareholders of HK$787,000 (2002: HK$9,393,000) for the period and on the total number of 389,500,000 (2002: 389,500,000) ordinary shares in issue during the period. No information in respect of diluted earnings per share is presented for the six months ended 30th September, 2003 and 2002 as there is no dilutive potential ordinary share for these periods.